Proposed Placing of new ordinary shares to raise at least £1.5 million
22 June 2022
Life Science
NetScientific PLC, the life sciences and sustainability technology investment and commercialisation group, is pleased to announce that the Company is carrying out an equity fundraising to raise at least £1.5 million (the “Placing”), before expenses, via the issue of an …
Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth
15 June 2022
Fintech
Life Science
Technology
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group announces that portfolio company Q-Bot has successfully closed a £1.62m investment round to fund the next stage of its growth. The additional funds will allow …
PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101
6 June 2022
Life Science
NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has been granted Fast Track designation for PDS0101 in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® …
Foxberry expands in Australia with Foxf9 developed BetaShares ETF
Life Science
Sustainability
Technology
London, 2 June 2022 Foxberry Ltd, the provider of financial indices and front-office technology for the financial sector, today announced that BetaShares in Australia has chosen Foxberry as the index provider for its new Future of Food ETF investing in the …
PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine
28 January 2022
Life Science
Technology
London, UK – 28 January 2022 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS”), announced yesterday preclinical data for its universal flu vaccine, …
Q-Bot Investment and Share Acquisition – NetScientific Plc
5 January 2022
Life Science
Q-Bot Investment and Share Acquisition NetScientific takes c.19% direct stake in construction industry robotics company Q-Bot and leads Convertible Loan round London, UK – 21 December 2021 – NetScientific plc (AIM:NSCI), the international life sciences and sustainability technology investment and commercialisation Group, …
EMVC syndicates additional £0.73m investment
13 December 2021
Life Science
Technology
Syndication highlights strength of capital light investment model London, UK – 13 December 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that on 9 December 2021 its corporate finance and venture …
PDS Phase 2 Clinical Trial Update
6 December 2021
Life Science
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination London, UK – 06 December 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio …
Sofant Signs €7.3m European Space Agency Contract
8 November 2021
Life Science
Technology
London, UK – 4 November 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, Sofant Technologies ("Sofant"), the leading 5G and Satcom antenna developer based in Edinburgh, has …
EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer Sofant Technologies
26 October 2021
Life Science
London, UK – 26 October 2021 – NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its corporate finance and venture capital division EMV Capital Ltd ("EMVC") advised on a £843k fundraise, made …